Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Molecular prognostic markers in ovarian cancer: toward patient-tailored therapyA P G Crijns, E W Duiker, S de Jong, et al.Journal of Clinical Pathology|July 9, 2002
The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometriumM J E Mourits, K A Ten Hoor, A G J van der Zee, et al.The Netherlands Journal of Medicine|June 21, 2002
Cardiovascular abnormalities in patients with a carcinoid syndromeW C Meijer, D J van Veldhuisen, I P Kema, et al.Psychopharmacology|April 16, 2003
Neuropsychological investigation into the carcinoid syndromeS Russo, M M A Nielen, J C Boon, et al.European Journal of Cancer (Oxford, England : 1990)|August 4, 2006
The clinical trail of TRAILE W Duiker, C H Mom, S de Jong, et al.British Journal of Clinical Pharmacology|October 16, 2007
Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic-pharmacodynamic studyM Joerger, A D R Huitema, M T Huizing, et al.Gynecologic Oncology|February 20, 2007
Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohortC H Mom, M J A Engelen, P H B Willemse, et al.European Journal of Cancer (Oxford, England : 1990)|February 10, 2009
Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancerM J A Engelen, B J Snel, M Schaapveld, et al.Anticancer Research|March 16, 2004
Paclitaxel and carboplatin concurrent with radiotherapy for primary cervical cancerF Y F L de Vos, A M E Bos, J A Gietema, et al.European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy; cardiovascular risk factors and signs of vascular damageF Y F L de Vos, J Nuver, P H B Willemse, et al.Pageof 3